- Home
- HXHX vs MBRX Comparison
HXHX vs MBRX Comparison
Compare HXHX & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HXHX
- MBRX
- Stock Information
- Founded
- HXHX 2003
- MBRX 2015
- Country
- HXHX China
- MBRX United States
- Employees
- HXHX N/A
- MBRX N/A
- Industry
- HXHX Trucking Freight/Courier Services
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- HXHX Industrials
- MBRX Health Care
- Exchange
- HXHX Nasdaq
- MBRX Nasdaq
- Market Cap
- HXHX 19.0M
- MBRX 17.1M
- IPO Year
- HXHX 2025
- MBRX 2016
- Fundamental
- Price
- HXHX $1.00
- MBRX $0.57
- Analyst Decision
- HXHX
- MBRX Strong Buy
- Analyst Count
- HXHX 0
- MBRX 3
- Target Price
- HXHX N/A
- MBRX $5.33
- AVG Volume (30 Days)
- HXHX 134.7K
- MBRX 2.5M
- Earning Date
- HXHX 01-01-0001
- MBRX 08-12-2025
- Dividend Yield
- HXHX N/A
- MBRX N/A
- EPS Growth
- HXHX N/A
- MBRX N/A
- EPS
- HXHX 0.26
- MBRX N/A
- Revenue
- HXHX $25,571,810.00
- MBRX N/A
- Revenue This Year
- HXHX N/A
- MBRX N/A
- Revenue Next Year
- HXHX N/A
- MBRX N/A
- P/E Ratio
- HXHX $3.39
- MBRX N/A
- Revenue Growth
- HXHX N/A
- MBRX N/A
- 52 Week Low
- HXHX $0.84
- MBRX $0.25
- 52 Week High
- HXHX $6.29
- MBRX $3.65
- Technical
- Relative Strength Index (RSI)
- HXHX N/A
- MBRX 43.74
- Support Level
- HXHX N/A
- MBRX $0.54
- Resistance Level
- HXHX N/A
- MBRX $0.61
- Average True Range (ATR)
- HXHX 0.00
- MBRX 0.05
- MACD
- HXHX 0.00
- MBRX -0.01
- Stochastic Oscillator
- HXHX 0.00
- MBRX 14.53
About HXHX Haoxin Holdings Limited Class A Ordinary Shares
Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.